Therapeutic effect of extracorporeal shockwave therapy for meniscal degenerative tear

JRCT ID: jRCTs032200082

Registered date:01/09/2020

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Meniscal degenerative tear
• Date of first enrollment: 08/09/2020
• Target sample size: 30
• Study type: Interventional
• Intervention(s): Extracorporeal shockwave therapy

Outcome(s)

• Primary Outcome: T2 value in MRI

Secondary Outcome

Patient background (Age, Sex, Height, Weight, Body mass index, Medical history, Comorbidities, Drinking history, Smoking history)
ESWT conditins (Energy flow density, Freaquency, Total energy)
NRS (Walking, going up and down stairs)
Clinical score (KOOS, IKDC score, Lysholme score)
Scientific findings (Ballottement of patella, Range of motion, Mcmurray test, Watson-Jones test, Lachman test, Posterior drawer test)
Adverse event
Daily use of oral analgesics
Transition rate to surgery after starting treatment

Key inclusion & exclusion criteria

• Age minimum: >= 40age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1) Patients over 40 years old
2) Patients diagnosed with meniscal degeneration by MRI
3) Patients with knee pain above NRS2
4) Patients with PS between 0 and 1
5) Outpatient
6) Patients obtained from consent documents

Exclude criteria

1) Patients with knee osteoarthritis of G3 or higher according to the Kellgren-Lawrence classification
2) Patients diagnosed with cognitive decline at the physician's discretion
3) Patients with untreated blood coagulation disorders such as hemophilia or patients taking anticoagulants
4) Patients with thrombosis
5) Patients with malignant tumor
6) Pregnant woman
7) Patients who have received steroid treatment for 6 months or more, or within 6 weeks after steroid injection
8) Patients judged inappropriate by the doctor

Related Information

• Primary Sponsor: Chikuda Hirotaka
• Secondary ID(s): Nil known